Ország: Egyesült Királyság
Nyelv: angol
Forrás: MHRA (Medicines & Healthcare Products Regulatory Agency)
Acetazolamide
Advanz Pharma
S01EC01
Acetazolamide
500mg
Powder for solution for injection
Intravenous; Intramuscular
No Controlled Drug Status
Valid as a prescribable product
BNF: 11060000; GTIN: 5021691165378
IF ANY OF THE SIDE EFFECTS BECOMES SERIOUS, OR IF YOU NOTICE ANY SIDE EFFECTS NOT LISTED IN THIS LEAFLET, PLEASE TELL YOUR DOCTOR OR PHARMACIST. REPORTING OF SIDE EFFECTS: If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on the safety of this medicine. 5. HOW TO STORE DIAMOX INJECTION Keep out of the sight and reach of children. Do not use after the expiry date. This date is printed on your pack. The Expiry date refers to last day of that month. Do not store above 25˚C. Any unused solution can be stored in a refrigerator for up to 24 hours but any unused solution after this period must be discarded. For single use only. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment. 6. FURTHER INFORMATION WHAT DIAMOX INJECTION CONTAINS: The active substance is acetazolamide. Each vial contains 500mg acetazolamide. The other ingredients are sodium hydroxide, hydrochloric acid and water for injection. WHAT DIAMOX INJECTION LOOK LIKE AND CONTENTS OF THE PACK: Diamox Injection is a white powder, packed in glass vials with a rubber ring and aluminium seal. Before use, it is made into a solution, using at least 5ml water for injection. MARKETING AUTHORISATION HOLDER AND MANUFACTURER: Mercury Pharmaceuticals Ltd., Capital House, 85 King William Street, London EC4N 7BL, UK This leaflet was last revised in December 2017. _Mercury Pharma Group Ltd. is licensed to use the registered trademark_ _Diamox._ LF-104036-01 PATIENT INFORMATION LEAFLET DIAMOX ® SODIUM 500MG POWDER FOR SOLUTION FOR INJECTION ACETAZOLAMIDE Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet. You may need to read it again. If you have Olvassa el a teljes dokumentumot
OBJECT 1 DIAMOX SODIUM 500MG POWDER FOR SOLUTION FOR INJECTION Summary of Product Characteristics Updated 15-Jan-2018 | Concordia International - formerly AMCo 1. Name of the medicinal product DIAMOX® Sodium 500mg Powder for Solution for Injection Acetazolamide 500mg Powder for solution for Injection. 2. Qualitative and quantitative composition Each vial contains Acetazolamide 500mg For full list of excipients see section 6.1. 3. Pharmaceutical form White to off-white powder for solution for injection. 4. Clinical particulars 4.1 Therapeutic indications Acetazolamide is an enzyme inhibitor which acts specifically on carbonic anhydrase. It is indicated in the treatment of : i) Glaucoma: DIAMOX injection is useful in glaucoma (chronic simple (open angle) glaucoma, secondary glaucoma and perioperatively in acute angle closure glaucoma where delay of surgery is desired in order to lower intraocular pressure) because it acts on inflow, decreasing the amount of aqueous secretion. ii) Abnormal retention of fluids: DIAMOX injection is a diuretic whose effect is due to the effect on the reversible hydration of carbon dioxide and dehydration of carbonic acid reaction in the kidney. The result is a renal loss of HCO3- ion which carries out sodium, water and potassium. DIAMOX injection can be used in conjunction with other diuretics when effects on several segments of the nephron are desirable in the treatment of fluid retaining states. iii) Epilepsy: In conjunction with other anticonvulsants best results with DIAMOX injection have been seen in petit mal in children. Good results, however, have been seen in patients, both children and adults, with other types of seizures such as grand mal, mixed seizure patterns, myoclonic jerk patterns, etc 4.2 Posology and method of administration Routes of Administration: Intravenous or intramuscular injection. The direct intravenous route is preferred as intramuscular use is limited by the alkaline pH of the solution. i) Glaucoma (simple acute congestive and secondary): Adults: 250 - 10 Olvassa el a teljes dokumentumot